Home > Healthcare > Healthcare IT > Telehealth > Digital Therapeutics Market
The surging prevalence of chronic conditions is projected to propel the demand globally. The substantial increase in the disease rates of chronic ailments such as obesity, diabetes, and cardiac conditions among others that lead to prolonged hospitalization, higher disease burden, and increased mortality rates are anticipated to prove beneficial for the industry growth. The incidence of diabetes is forecast to increase substantially in the elderly population aged 65 years or above. The management of such chronic diseases is generally multidimensional that comprises several aspects including the use of digital therapeutic software & devices thereby propelling the market expansion.
Digital therapeutics plays an anchoring role in chronic disease management as these solutions are proving to be one of the crucial factors in treatment. The rise in noncommunicable diseases (NCDs) and related mortality offers immense potential for market growth and opportunity for the market players to establish and penetrate the untapped market. Thus, the growing prevalence of chronic diseases is expected to expedite the digital therapeutics industry demand.